These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35640922)

  • 21. Contact force catheter ablation for the treatment of persistent atrial fibrillation: Results from the PERSIST-END study.
    Lo M; Nair D; Mansour M; Calkins H; Reddy VY; Colley BJ; Tanaka-Esposito C; Sundaram S; DeLurgio DB; Sanders P; Khatib S; Bernard M; Olson N; Gibson D; Miller A; Li J; Natale A
    J Cardiovasc Electrophysiol; 2023 Feb; 34(2):279-290. PubMed ID: 36352771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Moretz K; Poole JE; Mascette A; Rosenberg Y; Jeffries N; Al-Khalidi HR; Lee KL;
    Am Heart J; 2018 May; 199():192-199. PubMed ID: 29754661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registry.
    Zhou L; He L; Wang W; Li C; Li S; Tang R; Sang C; Liu N; Jiang C; Yu R; Long D; Du X; Dong J; Ma C
    Europace; 2023 Feb; 25(2):382-389. PubMed ID: 36156137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial.
    Haldar S; Khan HR; Boyalla V; Kralj-Hans I; Jones S; Lord J; Onyimadu O; Satishkumar A; Bahrami T; De Souza A; Clague JR; Francis DP; Hussain W; Jarman JW; Jones DG; Chen Z; Mediratta N; Hyde J; Lewis M; Mohiaddin R; Salukhe TV; Murphy C; Kelly J; Khattar RS; Toff WD; Markides V; McCready J; Gupta D; Wong T
    Eur Heart J; 2020 Dec; 41(47):4471-4480. PubMed ID: 32860414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between amiodarone response prior to ablation and 1-year outcomes of catheter ablation for atrial fibrillation.
    Yadav R; Brilliant J; Akhtar T; Milstein J; Sampognaro JR; Marine J; Berger R; Calkins H; Spragg D
    J Cardiovasc Electrophysiol; 2023 Apr; 34(4):860-868. PubMed ID: 36738148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study.
    Yu HT; Shim J; Park J; Kim IS; Kim TH; Uhm JS; Joung B; Lee MH; Kim YH; Pak HN
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28611206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of the 2nd generation cryoballoon for pulmonary vein isolation in patients with persistent atrial fibrillation - A sub-study of the randomized trial evaluating single versus dual cryoballoon applications.
    Mörtsell D; Jansson V; Malmborg H; Lönnerholm S; Blomström-Lundqvist C
    Int J Cardiol; 2019 Mar; 278():120-125. PubMed ID: 30409738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical Trial.
    Samuel M; Khairy P; Champagne J; Deyell MW; Macle L; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Tardif JC; Andrade JG
    JAMA Cardiol; 2021 Nov; 6(11):1324-1328. PubMed ID: 34406350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.
    Marrouche NF; Wazni O; McGann C; Greene T; Dean JM; Dagher L; Kholmovski E; Mansour M; Marchlinski F; Wilber D; Hindricks G; Mahnkopf C; Wells D; Jais P; Sanders P; Brachmann J; Bax JJ; Morrison-de Boer L; Deneke T; Calkins H; Sohns C; Akoum N;
    JAMA; 2022 Jun; 327(23):2296-2305. PubMed ID: 35727277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefit of left atrial appendage electrical isolation for persistent and long-standing persistent atrial fibrillation: a systematic review and meta-analysis.
    Romero J; Michaud GF; Avendano R; Briceño DF; Kumar S; Carlos Diaz J; Mohanty S; Trivedi C; Gianni C; Della Rocca D; Proietti R; Perrotta L; Bordignon S; Chun JKR; Schmidt B; Garcia M; Natale A; Di Biase L
    Europace; 2018 Aug; 20(8):1268-1278. PubMed ID: 29342299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
    Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
    JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study.
    Pak HN; Park J; Park JW; Yang SY; Yu HT; Kim TH; Uhm JS; Choi JI; Joung B; Lee MH; Kim YH; Shim J
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008531. PubMed ID: 32755396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project.
    Perego GB; Iacopino S; Molon G; Arena G; Verlato R; Pieragnoli P; Curnis A; Allocca G; Nicolis D; Sciarra L; Catanzariti D; Senatore G; Rovaris G; Brasca F; Tondo C;
    J Cardiol; 2019 Jul; 74(1):19-26. PubMed ID: 30948185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phased RF ablation in persistent atrial fibrillation.
    Hummel J; Michaud G; Hoyt R; DeLurgio D; Rasekh A; Kusumoto F; Giudici M; Dan D; Tschopp D; Calkins H; Boersma L;
    Heart Rhythm; 2014 Feb; 11(2):202-9. PubMed ID: 24239841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting the progression from paroxysmal to persistent atrial fibrillation despite an index catheter ablation.
    Li GY; Elimam AM; Lo LW; Lin YJ; Chang SL; Hu YF; Chung FP; Chao TF; Lin CY; Liu CM; Liao JN; Ton AK; Yugo D; Lin L; Tuan TC; Kao PH; Liu SH; Chhay C; Kuo L; Cheng WH; Chen WT; Chen SA
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2504-2513. PubMed ID: 37822117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation.
    Santangeli P; Zado ES; Hutchinson MD; Riley MP; Lin D; Frankel DS; Supple GE; Garcia FC; Dixit S; Callans DJ; Marchlinski FE
    Heart Rhythm; 2016 Feb; 13(2):374-82. PubMed ID: 26477712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.
    Mesquita J; Cavaco D; Ferreira AM; Costa FM; Carmo P; Morgado F; Mendes M; Adragão P
    J Interv Card Electrophysiol; 2018 Jun; 52(1):39-45. PubMed ID: 29511973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.
    Wynn GJ; Panikker S; Morgan M; Hall M; Waktare J; Markides V; Hussain W; Salukhe T; Modi S; Jarman J; Jones DG; Snowdon R; Todd D; Wong T; Gupta D
    Heart Rhythm; 2016 Feb; 13(2):399-406. PubMed ID: 26455343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
    Mont L; Bisbal F; Hernández-Madrid A; Pérez-Castellano N; Viñolas X; Arenal A; Arribas F; Fernández-Lozano I; Bodegas A; Cobos A; Matía R; Pérez-Villacastín J; Guerra JM; Ávila P; López-Gil M; Castro V; Arana JI; Brugada J;
    Eur Heart J; 2014 Feb; 35(8):501-7. PubMed ID: 24135832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.